AccuRef Diagnostics Emerges as a New Division of Applied StemCell,
Inc. With a Focus on Advancing Molecular Diagnostics Through Precision
Reference Standards

November 08, 2017 06:00 AM Eastern Standard Time

MILPITAS, Calif.--(BUSINESS WIRE)--AccuRef Diagnostics (ARD) is announcing its formation as a new division
under Applied StemCell, Inc., an ISO-certified global provider of
molecular and cellular reference standards for assay development,
proficiency testing, and quality control. The announcement comes as ARD
continues to expand its product catalog to generate the largest panel of
precision engineered reference standards on the market, with over 215
CRISPR-engineered variants in its oncology catalog, and greater than
1,500 products. “Our ultimate goal is to create a broad portfolio of
high value reference standards for routine use on multiple analysis
platforms and for multiple clinical diagnostics applications,” said
Gianluca Roma, Director of Marketing.

The expanding ARD product catalog provides both singleplex and dPCR
pre-validated multiplex reference standards in a diverse set of
biorelevant formats, including genomic DNA, FFPE cell blocks, slides and
scrolls, as well as matched frozen cell pellets. “Our Onco-Ref™ product
series spans everything from a single point mutation to 40+ dPCR
pre-validated quantitative multigene panels as part of our Quan-Plex™
product series,” said Dr. Sonika Saddar, Head of Product Development.

In addition to over 1,500 products, the Custom Diagnostics division of
ARD partners with pharmaceutical and diagnostics companies to develop
custom-engineered variants and pre-validated mutation panels to suit the
specific needs of these companies. “Founding of the new AccuRef
Diagnostics division emphasizes our commitment to helping advance the
molecular diagnostic industry, and strengthens our ongoing partnerships
with key diagnostic companies to develop custom reference standard
panels,” stated Dr. Ruhong Jiang, President and CEO of Applied StemCell,
Inc.

The formation of the division follows on the heels of Applied StemCell’s
recent announcement of full ISO 9001 and 13485 certifications at their
Milpitas location, which will be inclusive of the newly formed AccuRef
Diagnostics division.

About Applied StemCell, Inc.

Applied StemCell, Inc. is a global provider of gene editing and stem
cell-based services, as well as a leader in molecular and cellular
reference standard products for clinical diagnostics market. For more
information, please visit www.appliedstemcell.com.